SCHEDULE 13G: CVI Investments and Heights Capital Management Disclose 9.9% Stake in ReShape Lifesciences
Beneficial Ownership Report
CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., have jointly disclosed a beneficial ownership of 9.9% of ReShape Lifesciences Inc.'s common stock.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, "Reporting Persons") have filed a Schedule 13G, reporting their beneficial ownership in ReShape Lifesciences Inc.
- The Reporting Persons collectively beneficially own 344,626 shares of ReShape Lifesciences Inc. common stock.
- This ownership represents 9.9% of the company's outstanding common stock.
- The beneficially owned shares consist of 200,000 existing shares and additional shares issuable upon the exercise of warrants.
- The warrants are subject to a blocker provision, preventing exercise if it would result in beneficial ownership exceeding 9.99%.
- As of the completion of a recent offering on February 18, 2025, ReShape Lifesciences Inc. had 3,305,087 shares outstanding, excluding shares underlying the warrants.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing (Schedule 13G) disclosing beneficial ownership and does not convey positive or negative sentiment regarding the company's performance or prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
The document is a beneficial ownership report and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This filing indicates a significant investment by institutional entities in ReShape Lifesciences Inc., a company operating in the medical device or healthcare sector. Such disclosures are routine for investors acquiring substantial stakes and provide transparency regarding ownership structure.
Related Party Transactions
- Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc., and may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and trading activity.
- Company Management: Awareness of a significant shareholder and their potential influence on corporate decisions, although the filing states the shares were not acquired for the purpose of changing or influencing control.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of event which requires filing of this statement; also the date of completion of the offering of shares mentioned in the company's prospectus. |
| 02/21/2025 | Date of signature for the Schedule 13G filing. |
Keywords
ReShape Lifesciences Inc., CVI Investments Inc., Heights Capital Management Inc., Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.